Xiaoer Qishen Fugan Granule and its preparation method

Abstract

The invention relates to a Xiaoer Qishen Fugan granule and a preparation method thereof, comprising the raw materials in the following mass ratios: 323.3-343.3g of sunburned astragalus, 190.0-210.0g of salvia miltiorrhiza, 190.0-210.0g of bran-fried Atractylodes macrocephala, and 190.0-210.0g of tangerine peel , Radix Pseudostellariae 323.3‑343.3g, Radix Paeoniae Rubra 190.0‑210.0g, Ligusticum Chuanxiong 123.3‑143.3g, Chicken Gold in Vinegar 190.0‑210.0g. The Xiaoer Qishen Fugan granule of the present invention is "Supplementing Qi, Activating Blood and Yunpi Prescription", which has been verified to have a significant therapeutic effect on children with repeated respiratory tract infections. The formula focuses on replenishing qi, activating blood and transporting the spleen, highlighting the traditional Chinese medicine theory of "prolonged illness enters the collaterals"; while strengthening the body, the treatment runs through the principles of activating blood and dredging collaterals; clinical trials have been conducted for many years, and the curative effect is definite.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a pediatric Qishen Fugan granule and a preparation method thereof. Background technique [0002] Recurrent respiratory tract infection (RRTI) is a common and frequently-occurring disease in infants and young children. The incidence rate accounts for about 30% of respiratory tract infections in pediatric outpatient clinics, and patients with respiratory tract infection account for about 80% of the total number of pediatric outpatients. According to the RRTI diagnostic criteria formulated by the National Academic Conference on Pediatric Respiratory Diseases in 1987, children with upper or lower respiratory tract infections within a year exceeding a certain range are identified as children with recurrent respiratory tract infections, referred to as recurrent children. Its clinical manifestations vary depending on the site of infection, and are generally consistent with the correspo...

AI Technical Summary

Problems solved by technology

At present, there is no specific medicine for the treatment of RRTI in western medicine. During the acute infection period, antibiotics are mainly used to control the course of the disease from the perspective of symptomatic treatment. During the recovery period after infection, supplementing trace elements and regulating immunity can enhance the immune defense function of reinfected children. , in order to reduce the number of recurrent infections, but Western medicine often has the disadvantages of poor curative effect and many side effects.

Images